Oslo, 23 Oktober -- On 3 September, ContextVision AB ("ContextVision" or the
"Company") announced a share buy-back programme of up to NOK 10,000,000, with
a maximum of 4,000,000 shares, in the period from 5 September 2025 to 5 March
2026.
DNB Carnegie, acting under the mandate from ContextVision, has carried out the
following transactions under the buy-back programme:
+---------------------+------------------+---------------+-------------------+
| Date | Aggregated daily | Weighted | Total daily |
| | volume (number | average share | transaction value |
| | of shares) | price per day | (NOK) |
| | | (NOK) | |
+---------------------+------------------+---------------+-------------------+
| 2025-10-15 | 12 072 | 4,4694 | 54 035,48 |
+---------------------+------------------+---------------+-------------------+
| 2025-10-16 | 11 999 | 4,5000 | 53 995,50 |
+---------------------+------------------+---------------+-------------------+
| 2025-10-17 | 7 554 | 4,4300 | 34 030,77 |
+---------------------+------------------+---------------+-------------------+
| 2025-10-20 | 5 212 | 4,5253 | 23 585,86 |
+---------------------+------------------+---------------+-------------------+
| 2025-10-21 | 8 271 | 4,4511 | 36 859,71 |
+---------------------+------------------+---------------+-------------------+
| 2025-10-22 | 7 244 | 4,4285 | 32 093,09 |
+---------------------+------------------+---------------+-------------------+
| 2025-10-23 | 11 664 | 4,4540 | 51 854,64 |
+---------------------+------------------+---------------+-------------------+
| Previously | 304 633 | 4,5437 | 1 386 282,42 |
| disclosed buy-buys | | | |
| under the programme | | | |
| (accumulated) | | | |
+---------------------+------------------+---------------+-------------------+
| Accumulated under | 368 649 | 4,5284 | 1 672 737,48 |
| the buy-back | | | |
| programme | | | |
+---------------------+------------------+---------------+-------------------+
Following the completion of the above transactions, ContextVision owns a total
of 1 746 811 of own shares, corresponding to 2.26% of ContextVision's share
capital.
An overview of all transactions made under the buy-back programme that have
been carried out during the abovementioned time period is attached to this
report and available at www.newsweb.no (http://www.newsweb.no/).
For further information, please contact:
Richard Hallström, CFO
Email: richard.hallstrom@contextvision.com
About ContextVision AB:
ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound,
X-ray and MRI equipment around the world. Our expertise is to develop powerful
software products, based on proprietary technology and artificial intelligence
for image-based applications. Our cutting-edge technology helps clinicians
accurately interpret medical images, a crucial foundation for better diagnosis
and treatment. The company, established in 1983, is based in Sweden with local
representation in the U.S., Japan, China and Korea. ContextVision is listed on
the Oslo Stock Exchange under the ticker CONTX.
This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication at
2025-10-23 17:08 CEST.